glp-1 discontinuation 🔬 GLP-1/GIP Therapy Discontinuation: Why the “How” Matters One of the most-discussed challenges with GLP-1/GIP agonists such as tirzepatide (Mounjaro®) is weight regain after stopping therapy. What… | Paramesh Shamanna Trajectory of the body weight

Combined with a healthy diet and exercise, this blend maximizes weight loss by targeting appetite, metabolism, and gut health for sustainable results

The treatment, which operates by targeting glucagon-like peptide-1 (GLP-1) receptors, falls within a class of drugs that are designed to affect the bodys insulin production and blood sugar levels

Get licensed treatments, trusted advice and NHS services with fast, discreet delivery.

This plan is backed by the scientist, Ben Bikman, who studies insulin resistance, weight loss, and why people get sick

Reduced risk of side effects

Attia's perspective and delve into the relationship between GLP-1 and muscle mass in this piece.